Opinion and Evidence in Respiratory Medicine
- PDF / 99,208 Bytes
- 5 Pages / 612 x 790.56 pts Page_size
- 36 Downloads / 203 Views
Am J Respir Med 2002; 1 (5): 375-379 1175-6365/02/0005-0375/$25.00/0 © Adis International Limited. All rights reserved.
Opinion and Evidence in Respiratory Medicine Contents Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1. Quality of Life Improved with Budesonide Versus Fluticasone Propionate . . . . . . . . . 2. Ketolides: New Weapon in the Fight Against Respiratory Infections . . . . . . . . . . . . 3. Vascular Endothelial Growth Factor Prevents Respiratory Distress Syndrome . . . . . . . 4. Moxifloxacin More Effective than Amoxicillin/Clavulanic Acid in Pneumonia . . . . . . . 5. Hydrofluoroalkane-Beclomethasone Cost Effective for Asthma in the UK . . . . . . . . . 6. Inhaled Ethyl Nitrite Effective in Pulmonary Hypertension . . . . . . . . . . . . . . . . . . 7. Surfactant Lavage for Meconium Aspiration Syndrome . . . . . . . . . . . . . . . . . . . 8. Tiotropium Bromide Improves Quality of Life in Chronic Obstructive Pulmonary Disease 9. Budesonide + Itraconazole Associated with Adrenal Insufficiency . . . . . . . . . . . . . 10. Aerosolised Iloprost Effective in Pulmonary Hypertension . . . . . . . . . . . . . . . . . . 11. Aspirin May Prevent Lung Cancer in Women . . . . . . . . . . . . . . . . . . . . . . . . . 12. Clarithromycin: Role in Asthma? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
. . . . . . . . . . . . .
375 375 375 376 376 377 377 377 378 378 378 379 379
Respiratory Medicine is a vast and evolving area for researchers, primary care physicians and specialists. To help keep you up-to-date with the latest advances worldwide on all aspects of drug therapy and management of respiratory disorders, this section of the journal brings you information selected from the drug therapy reporting service Inpharma Weekly1. The following reports are selected from the latest issues, summarizing the most important research and development news, clinical studies, treatment guidelines, pharmacoeconomic and adverse reaction news, and expert opinion pieces published across a broad range of literature sources.
1. Quality of Life Improved with Budesonide Versus Fluticasone Propionate Budesonide is associated with greater improvements in quality of life (QOL) among patients with moderate-to-severe seasonal allergic rhinitis than fluticasone propionate, say researchers from Italy and France. Their prospective study involved outcomes data for 121 such patients in France who were randomized to receive budesonide 1
Data Loading...
